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Voltage sensitive phosphatases (VSPs), including engineered voltage sensitive PTEN,
are excellent tools to rapidly and reversibly alter the phosphoinositide (PI) content of the
plasma membrane in vivo and study the tumor suppressor PTEN. However, widespread
adoption of these tools is hampered by the requirement for electrophysiological
instrumentation to control the activity of VSPs. Additionally, monitoring and quantifying
the PI changes in living cells requires sophisticated microscopy equipment and image
analysis. Here we present methods that bypass these obstacles. First, we explore
technically simple means for activation of VSPs via extracellularly applied agents or light.
Secondly, we characterize methods to monitor PI(4,5)P2 and PI(3,4,5)P3 levels using
fluorescence microscopy or photometry in conjunction with translocation or FRET based
PI probes, respectively. We then demonstrate the application of these techniques by
characterizing the effect of known PTEN mutations on its enzymatic activity, analyzing
the effect of PTEN inhibitors, and detecting in real time rapid inhibition of protein kinase
B following depletion of PI(3,4,5)P3. Thus, we established an approach that does not
only allow for rapidly manipulating and monitoring PI(4,5)P2 and PI(3,4,5)P3 levels in a
population of cells, but also facilitates the study of PTEN mutants and pharmacological
targeting in mammalian cells.
Keywords: phosphoinositides, signal transduction, cancer, fluorescence resonance energy transfer, voltage
sensitive phosphatase (VSP), phosphatase and tensin homolog (PTEN), tumorigenic mutations, PI3-kinase
signaling
Introduction
Phosphoinositides (PIs) are membrane-bound signaling molecules essential for many cellular pro-
cesses like migration, proliferation, membrane trafficking, and regulation of ion channels (Balla
et al., 2009). Various experimental techniques have been developed to control PI levels in living
cells, ranging from pharmacological approaches and genetic manipulations such as over-expression
or knock-down of PI-metabolizing enzymes, to more dynamic approaches that allow temporal con-
trol over PI levels. Three distinct approaches for the acute manipulation of PI concentrations have
been developed, all displaying certain limitations that need to be considered.
First, the FKBP-FRB heterodimerization system recruits a PI metabolizing enzyme (e.g.,
PI(4,5)P2-5-phosphatase) to the membrane when rapamycin is applied (Suh et al., 2006;
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Varnai et al., 2006). The timing of recruitment and consequently
the change in, e.g., PI(4,5)P2 concentration can be controlled
with precision on the order of seconds. However, recruitment
and hence the alteration of PI levels is irreversible. Furthermore,
the use of the rapamycin-induced dimerization system is limited
to cell types that do not express large amounts of FKBP or FRB
protein domains endogenously (Coutinho-Budd et al., 2013) and
unwanted effects via endogenous targets of rapamycin have to be
considered (Brown et al., 1994).
The second technique is similar, being based on the
recruitment of PI-phosphatases to the membrane controlled by
light-induced dimerization of CRY2 and CIBN domains (Idevall-
Hagren et al., 2012). This approach allows for PI(4,5)P2 depletion
that is reversible within minutes, but it has limitations concern-
ing the analysis of PI levels using standard fluorescent biosensors,
as the system is highly sensitive to blue and green light.
A third strategy to manipulate PI levels in living cells uti-
lizes voltage sensitive phosphatases (VSPs) that have been iso-
lated from several chordates (Murata et al., 2005; Hossain et al.,
2008; Ratzan et al., 2011). VSPs consist of a voltage-sensing
transmembrane domain (VSD) linked to a cytoplasmic phos-
phatase domain. Membrane depolarization activates the protein
resulting in dephosphorylation of PIs. Although their biologi-
cal function remains largely unknown, VSPs have proven to be
highly useful to manipulate PI levels experimentally. For exam-
ple, the Ciona intestinalis VSP (Ci-VSP), which primarily acts as
a 5-phosphatase toward PI(4,5)P2and PI(3,4,5)P3 (Iwasaki et al.,
2008; Halaszovich et al., 2009), has been used to study regulation
of ion channels by PI(4,5)P2 (Lindner et al., 2011; Yudin et al.,
2011).
The potency and versatility of this strategy has recently been
expanded by the development of engineered voltage sensitive
enzymes (Lacroix et al., 2011; Halaszovich et al., 2012). One such
enzyme is the chimeric VSP PTENCiV(termed “Ci-VSPTEN16”
in (Lacroix et al., 2011)), where the PI(3,4)P2/PI(3,4,5)P3 3-
phosphatase PTEN (phosphatase and tensin homolog deleted
from chromosome 10) replaces the phosphatase domain of Ci-
VSP. PTENCiV is activated by depolarization of the membrane
potential while fully retaining enzymatic properties of wild-
type PTEN including substrate specificity (Lacroix et al., 2011).
Accordingly, PTENCiV can be used as a tool to manipulate
PI(3,4)P2 and PI(3,4,5)P3 levels.
Of note, PTEN itself has been the focus of extensive research
efforts, since it is one of the most frequently mutated tumor sup-
pressor genes in human cancer (Chalhoub and Baker, 2009) and
in hamartoma-related syndromes (Hollander et al., 2011); PTEN
dysfunction is also linked to autism spectrum disorders (ASDs)
Abbreviations: ASDs, autism spectrum disorders; bpV, bisperoxovanadium; C-
tail, the carboxyl-terminus domain; ChR2, channelrhodopsin-2; Ci-VSP, Ciona
intestinalis voltage sensitive phosphatase; COSMIC, Catalogue of Somatic Muta-
tions in Cancer; FHA1, forkhead-associated domain; FOXO1, forkhead box 1;
FRET, Förster resonance energy transfer; P-loop, phosphatase binding loop; PBM,
PIP2 binding module; PDZ, postsynaptic density protein-Drosophila disc large
tumor suppressor-zonula occludens 1 protein domain; PH, pleckstrin homology;
PI, phosphoinositide; PI3K, phosphatidylinositol 3-kinase; PKB, protein kinase B;
PTEN, phosphatase and tensin homolog deleted from chromosome 10; PTENCiV,
PTENwith Ciona intestinalis voltage sensor domain; TIRF, total internal reflection
fluorescence; VSD, voltage sensor domain; VSP, voltage sensitive phosphatase.
(Varga et al., 2009). Despite the significance of PTEN mutations
in pathological conditions, there are only limited techniques to
evaluate the effects of these mutations on the phosphatase activity
of the protein. These include in vitro phosphatase assays and the
functional analysis of PTEN in a yeast survival model (Cid et al.,
2008). There is a need for methods to fully characterize PTEN
activity in living mammalian cells. When combined with estab-
lished fluorescence-based methods for reading out PI concen-
trations, the voltage-controlled PTENCiV chimera may provide
an ideal platform for analyzing PTEN and its mutants in living
cells.
One major drawback in using VSPs for analyzing PI func-
tions and PTEN properties in living cells is the need for rather
sophisticated methods and expertise for the control of the mem-
brane potential, usually by patch clamp electrophysiology (e.g.,
Halaszovich et al., 2009; Sakata et al., 2011). Other disadvan-
tages are the time consuming single cell technique and pertur-
bation of the cell interior by whole-cell patch clamping. Here,
we report the development of a novel experimental strategy
to activate VSPs and PTENCiV without the use of electrophys-
iological instrumentation, enabling rapid, reversible, scalable,
and broadly applicable manipulation of PI levels in a popu-
lation of intact cells. Thus, we show that chemical or light
induced activation of cation channels can be employed to depo-
larize the membrane potential and thereby activate Ci-VSP or
PTENCiV. Similarly, we present PTENCiV as a novel approach
to study PTEN mutations and inhibitors with high precision.
Furthermore, we demonstrate that PTENCiV can also be used
to study the ubiquitous PI(3,4,5)P3/Protein kinase B (PKB, Akt)
pathway on a time scale not easily accessible to biochemical
approaches.
Materials and Methods
Molecular Biology
The chimeric construct PTENCiV was described previously
(Lacroix et al., 2011). The Frubby construct was created from
the Pippi-PI(4,5)P2 sensor kindly provided fromDr.M.Matsuda,
Japan (Yoshizaki et al., 2007), by replacing the PLCδ1-PH domain
with the tubbyC domain (Santagata et al., 2001). To remove
PLCδ1-PH from the original plasmid we used the BspE1 and
Kpn1 restriction sites. The same restriction sites were utilized to
insert tubbyC into the construct. The amino acid sequence of this
novel construct is provided as a Supplementary file. The AktAR
construct was kindly provided from Dr. J. Zhang, Baltimore,
USA (Gao and Zhang, 2008). Mutagenesis was performed using
the QuickChangeII XL Site-Directed mutagenesis kit (Agilent
Technologies, Santa Clara, CA).
Plasmids and Transfection
CHO and HEK 293 cells were plated on glass coverslips or—
for TIRF experiments—glass bottom dishes (WillCo Wells B.
V., Amsterdam, The Netherlands). For HEK 293 cells the glass
was coated with poly-D-lysine. Cells were transfected 24–48 h
later using JetPEI (Polyplus Transfection, Illkirch, France) as
described (Halaszovich et al., 2009). For the used expression
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vectors see Supplementary Table S1. Bovine phosphatidylinos-
itol 3-kinase p110α (constitutively active mutant K227E) was
cotransfected with PTENCiV to increase PI(3,4,5)P3 levels except
for experiments involving AktAR (Rodriguez-Viciana et al.,
1996). In the latter experiments, PI(3,4,5)P3 levels were ele-
vated by incubating the cells with 0.4 ng/µl insulin-like growth
factor-1 (Sigma, St.Louis, MO) for 15min (Halaszovich et al.,
2009). HEK cells were preferred for confocal imaging, since
they present a stronger membrane localization of PI markers.
Experiments were performed at room temperature 24–48 h after
transfection.
Fluorescence Microscopy
Confocal images were acquired using a Zeiss LSM710 Examiner
upright microscope and a W-Plan-Apochromat 20 × 1.0 DIC
M27 objective (Carl Zeiss AG; Jena; Germany). For excitation,
laser lines of 561 nm for RFP and 488 nm for GFP were used.
For detection, wavelength ranges were 582–754 nm for RFP and
493–582 nm for GFP. ChR2 was activated using an HBO lamp
with excitation band-pass filters 470/40 nm (blue) and 436/20 nm
(violet).
TIRF (Total Internal Reflection Fluorescence) imaging was
performed by using a B×51WI upright microscope with a
TIRF-condenser (Olympus, Hamburg, Germany) and a 488 nm
laser (Picarro, Sunnyvale, CA). The setup was equipped with a
LUMPIan FI/IR 40x/0.8- numerical aperture water immersion
objective (Olympus), an IMAGO-QE cooled CCD camera (TILL
Photonics GmbH, Grafelfing, Germany) and a monochromator
(Polychrome IV, TILL Photonics).
Widefield illumination FRET (Förster Resonance Energy
Transfer) was gained using a Nikon Eclipse TE2000-U inverted
microscope equipped with a 40 × 0.55 LWD objective and cou-
pled with an Oligochrome (TILL Photonics) light source. CFP
and YFP were excited using a 430/24 nm (F49-430, AHF Analy-
sentechnik, Tubingen, Germany) filter or a 500/20 nm (F49-500,
AHF) filter respectively. Emission signal passed first through a
tripleband beamsplitter CFP/YFP/mCherry (F68-017, AHF) and
next detection area was selected using a viewfinder and a uEye
camera (TILL Photonics). For CFP and YFP/FRET emission
detection, a 470/23 nm (F49, AHF) and a 535/30 nm filter respec-
tively, were placed before the photodiodes (TILL Photonics).
Photocurrent was amplified by Oligochrome Imaging Control
Unit, transmitted to an EPC-10 amplifier (HEKA electronics,
Lambrecht, Germany) and data acquisition and analysis were
performed with PatchMaster software (HEKA).
Patch Clamping
Whole-cell patch clamping was performed in CHO cells using an
EPC-10 amplifier and PatchMaster (both HEKA). Patch pipettes’
resistance was typically 1.5–4.0 M, recordings were sampled at
20 kHz and low-pass-filtered at 5 kHz. For current clamp record-
ings, cells were held at 0 pA and changes of membrane volt-
age were recorded upon 1 s blue light exposure. PTENCiV was
activated by 30 s voltage steps from a holding potential of −60
to +80mV. Sensing currents from PTENCiV were measured as
a result of a voltage jump to +120mV from a holding poten-
tial of −70mV with subtraction of linear leak and capacitive
transient currents.
Solutions and Chemicals
In most experiments, cells were kept in extracellular solution
containing (mM) 144 NaCl, 5.8 KCl, 0.9 MgCl2, 1.3 CaCl2, 0.7
NaH2PO4, 5.6 D-glucose, and 10 HEPES, pH 7.4 (with NaOH),
305–310 mosm/kg. Solutions with increased K+ concentration
were made by replacing NaCl with KCl. For maximal depolar-
ization, a 150mM K+ solution was required prepared as follows
(mM): 150 KCl, 0.9 MgCl2, 1.3 CaCl2, 0.7 NaH2PO4, 5.6 D-
glucose, and 10 HEPES, pH 7.4 (with KOH). For the TRPV1 and
ChR2(H134R) experiments Ca2+ was omitted from the standard
extracellular solution to prevent the Ca2+ dependent activation
of phospholipases-C (PLC) (Ca2+-free extracellular solution)
(Rebecchi and Pentyala, 2000). Intracellular solution used for
patch clamp experiments contained (mM) 135 KCl, 2.41 CaCl2,
2.5 MgCl2, 5 EGTA, 5 HEPES, and 3 Na2-ATP, pH 7.3 (with
KOH), 290–295 mosm/kg.
Capsaicin and insulin-like growth factor-1 were purchased
from Sigma-Aldrich, the bisperoxovanadate from Santa Cruz
Biotechnology (Dallas, TX), DTT from Fermentas (St. Leon-Rot,
Germany).
Data Analysis and Statistics
Confocal microscopy data acquisition was performed using
ZEN2009 (Zeiss) software. For time series recordings, the fluo-
rescence was averaged for regions in the cytosol (Fcyt) and nor-
malized to the baseline fluorescence prior to stimulation (F0).
TIRF image analysis was performed using TILLvision software,
and the background-corrected TIRF signal was normalized to F0.
For FRET recordings, fluorescence intensity from a wide area
including several cells—except for AktAR experiments, were flu-
orescence was collected from a single cell—was acquired and pro-
cessed with PatchMaster. FRET ratios, calculated as fFRET/fCFP,
were normalized to the baseline before stimulation. fCFP and
fFRET were the signals from the CFP and FRET emission chan-
nels, corrected for the dark current recorded without illumi-
nation. IgorPro (Wavemetrics, Lake Oswego, OR) software was
used for data analysis and presentation. To calculate the max-
imal response to K+ or capsaicin, values acquired during the
last 30 s of the application were averaged. For ChR2-mediated
Ci-VSP activation, the maximal response represents the first
value acquired after the blue light exposure. To acquire the ini-
tiation kinetics using KCNQ4 and TRPV1, we calculated the
time required to reach 50% of the maximal response [t(1/2) of
initiation], for each individual cell. For recovery kinetics, the
time required to reach 50% of the baseline after the end of the
application was calculated [t(1/2) of recovery]. For ChR2 initi-
ation kinetics analysis, we utilized the blue light exposure time
curve (Figure 1H) to calculate t(1/2) of initiation. Only cells that
demonstrated a fluorescence intensity change greater than 4%
upon application of the substance were used for the analysis.
Error bars show the S.E.M, n represents the number of cells and
e represents the number of experiments. For statistical analysis,
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FIGURE 1 | Activation of Ci-VSP by membrane depolarization through
overexpressed cation channels. (A) Scheme representing the general
strategy used to activate Ci-VSP. Cells co-express Ci-VSP, a PI biosensor
and a cation channel. Cation influx into the cell results in membrane
depolarization, activation of Ci-VSP, depletion of PI(4,5)P2 and lastly
translocation of the sensor to the cytoplasm. BS, biosensor; PD,
phosphatase domain. (B) Confocal images of HEK cells co-expressing
Ci-VSP, KCNQ4 and tubbyC acquired before, during and after application of
150mM K+. Fluorescence signal was recorded from cytoplasmic regions.
Scale bar 20µm. (C) Time series of relative increase of cytoplasmic
fluorescence calculated from CHO cells expressing Ci-VSP, tubbyC-GFP and
the K+ permeable channels TASK-3 (n = 48, e = 16), KCNQ4 (n = 82,
e = 16) or no channel (n = 28, e = 9). The catalytically dead mutant Ci-VSP
C363S (n = 23, e = 8) was used as negative control. tubbyC translocates to
the cytoplasm upon 150mM K+ application for 1min. (D) K+
concentration-response curve from HEK cells co-expressing Ci-VSP,
tubbyC-GFP, and KCNQ4 (n = 15, e = 6). (E) Application of 100 nM
capsaicin in HEK cells co-expressing TRPV1 channel, Ci-VSP and
tubbyC-GFP resulted in Ci-VSP activation and tubbyC translocation (n = 25,
e = 8). No effect was observed in the absence of Ci-VSP (n = 19, e = 7) or
TRPV1 (n = 16, e = 6). (F) Capsaicin concentration-response curve (EC50 =
29 ± 3 nM; at least 10 cells per concentration). (G) Activation of ChR2 with
violet (426–446 nm) or blue (450–490 nm) light exposure for 10 s in HEK cells
co-expressing tubbyC-RFP and Ci-VSP. tubbyC translocation was observed
only at extracellular pH 6.5 (n = 12, e = 4), but not at pH 7.5 (n = 11, e = 4)
or with the catalytically dead Ci-VSP C363S mutant (n = 23, e = 4). (H)
Exposure time-response curve showing that 10 s of exposure with blue light
resulted in maximal tubbyC translocation.
a two-tailed Dunnett’s test was performed to compare the sin-
gle control to different experimental groups, two-tailed Student’s
t-test was used to compare two groups and Scheffe’s test formulti-
ple comparisons. Statistical significance was assigned at P < 0.05
and is marked as ∗ for the Dunnett’s and Scheffe’s test and as # for
Student’s t-test.
Results
Activation of Ci-VSP in Intact Cells by Membrane
Depolarization via Cation Channels
Activation of VSPs requires a depolarization of the membrane
potential. To facilitate cell-based assays using VSPs we aimed at
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eliminating complex electrophysiological instrumentation such
as patch clamp or two-electrode voltage clamp amplifiers from
the experimental setting. To this end, we developed the exper-
imental strategy depicted in Figure 1A, where cation channels
are used to depolarize the cell membrane, thereby activating
the VSP. The activity of the VSP can be monitored using
fluorescence-tagged biosensor specific for the VSP’s substrate
(Varnai and Balla, 2006).
We started by exploring cation channel based strategies to
activate the prototypical Ci-VSP, a PI(4,5)P2 5-phosphatase. First,
the K+ channels TASK-3 or KCNQ4 (Kv7.4) were used to
depolarize the cells. These channels are expected to be largely
or partially open under basal conditions, since TASK-3 is a
constitutively open “leak” channel (Enyedi and Czirjak, 2010),
whereas KCNQ4 is a voltage gated channel open at potentials
above −50mV, when expressed in CHO cells (Chambard and
Ashmore, 2005). Given that both channels provide a substantial
K+ conductance, cell depolarization can be simply achieved by
increasing the extracellular K+ concentration.
Indeed, we observed PI(4,5)P2 depletion as reported by
translocation of the PI(4,5)P2 biosensor tubbyC-GFP (Santagata
et al., 2001) when 150mM K+ was applied to cells co-expressing
Ci-VSP and either KCNQ4 or TASK-3 (Figures 1B,C). Strong
and rapid activation of Ci-VSP was achieved with either channel.
Slightly more cells co-transfected with KCNQ4 (92%) than cells
co-transfected with TASK-3 (80%) responded to application of
K+. Therefore KCNQ4 was used for further experiments. When
co-expression of channels was omitted, only 50% of the cells
responded to application of K+ and changes in PI(4,5)P2 con-
centration were weak (Figure 1C), indicating that in CHO cells
endogenous K+ channels were not sufficient to strongly drive
Ci-VSP activity. The translocation of tubbyC-GFP was com-
pletely absent when catalytically dead Ci-VSP C363S was used
(Figure 1C), confirming that K+-induced changes of PI(4,5)P2
were indeed mediated by activation of Ci-VSP.
VSPs can be used to deplete PIs in a gradual fashion by impos-
ing graded membrane depolarization (Halaszovich et al., 2009).
Membrane potential has a roughly logarithmic dependence on
extracellular [K+] when the K+ conductance is dominant, sug-
gesting that membrane potential and consequently Ci-VSP activ-
ity could be gradually increased by elevating extracellular [K+].
Indeed, when various K+ concentrations were washed in, Ci-VSP
activity measured as the degree of translocation of the biosen-
sor was also graded (Figure 1D). Maximum activity occurred at
150mM K+, which was the maximum concentration we could
achieve while keeping physiological osmolarity.
As an alternative approach to achieve membrane depo-
larization we utilized the capsaicin-activated TRPV1 channel
(Figure 1E), a non-selective cation channel that depolarizes the
membrane when active (Caterina et al., 1997). Because TRPV1 is
also Ca2+ permeable and Ca2+ influx could potentially activate
PLC (Rebecchi and Pentyala, 2000) causing PI(4,5)P2 cleavage,
we used Ca2+-free extracellular solutions in these experiments.
Application of capsaicin to HEK cells co-expressing TRPV1, Ci-
VSP and tubbyC-GFP resulted in readily detectable PI(4,5)P2
depletion as indicated by tubbyC-GFP translocation, whereas
no effect was observed in the absence of TRPV1 or Ci-VSP
(Figure 1E). 100 nM of capsaicin was sufficient to induce the
full response, as demonstrated by the capsaicin concentration-
response curve (Figure 1F).
Over the last years, light-activated prokaryotic ion channels
have been established as optogenetic tools for manipulation of
the membrane potential (Lin, 2011). Among these channels,
Channelrhodopsin-2 (ChR2), has been studied extensively and
used widely to depolarize cells. ChR2 is a non-selective cation
channel activated by visible light with a response spectral peak
at around 450 nm (Nagel et al., 2003; Lin et al., 2009). Since
activation by light could enable enhanced temporal control and
may facilitate experimentation, we also attempted to use ChR2 to
activate VSPs,
We first explored conditions for sufficient depolarization by
ChR2. Extracellular acidification (pH 6.5) turned out to strongly
increase the depolarization of cells expressing ChR2 when stimu-
lated with blue light (Supplementary Figure S1), most likely due
to the high H+ permeability of ChR2 (Nagel et al., 2003). This
finding suggested low extracellular pH as the optimal condition
to activate Ci-VSP via ChR2. Indeed, Ci-VSP was successfully
activated only when extracellular solution of pH 6.5 was used
but not at the standard extracellular pH 7.4 (Figure 1G). As in
the case of TRPV1, we used Ca2+-free solution to prevent activa-
tion of PLC by Ca2+ influx. 10 s of blue or violet light exposure
were sufficient for maximal stimulation of Ci-VSP, measured via
translocation of tubbyC-RFP to the cytoplasm (Figure 1H). An
RFP-tagged sensor was used in these experiments, because GFP
excitation interferes with ChR2 activation.
To compare the performance of the above methods of Ci-VSP
activation, we evaluated the maximal response to each stimulus
as well as the time required for PI(4,5)P2 depletion (i.e., sen-
sor translocation) and the time required for PI(4,5)P2 recovery
after cessation of the stimulus. Activation of all three channel
types resulted in robust sensor translocation. Specifically, Ci-VSP
activation induced by TRPV1 and ChR2 was slightly stronger
(sensor translocation 1.63 ± 0.09- and 1.65 ± 0.06-fold, respec-
tively), compared to the KCNQ4-mediated response (1.51 ±
0.04-fold increase; Figure 2A). However, these differences did
not reach statistical significance. The fastest response (Figure 2B)
was observed using ChR2 [t(1/2) = 4.4 ± 0.4 s], followed by
KCNQ4 [t(1/2) = 18.2 ± 1.8 s] and TRPV1 [t(1/2) = 25.0 ±
3.7 s]. For the recovery after stimulation, t(1/2) was 12.4 ± 1.2 s
for ChR2, 19.9 ± 2.7 s for KCNQ4 and 27.9 ± 3.1 s for TRPV1
(Figure 2C).
Monitoring Ci-VSP Activity without Imaging
The above method for monitoring PI depletion is based on
the translocation of PI sensors between cytosol and plasma
membrane. Detection of translocation requires imaging-based
experiments, usually involving confocal microscopy or advanced
microscopy techniques such as TIRF microscopy (van der Wal
et al., 2001; Varnai and Balla, 2008; Halaszovich et al., 2009).
Such approaches may not be optimal in many experimental
settings including high-throughput assays, because experiments
and analysis are based on single-cell data and thus are time-
consuming, may be difficult to automatize and involve costly
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FIGURE 2 | Comparison of the three depolarization methods in HEK
cells cotransfected with Ci-VSP, tubbyC, and one of the different
channels. (A) Bars representing the maximal response observed by
overexpression of KCNQ4, TRPV1, and ChR2. For KCNQ4 we used the
tubbyC translocation value from experiments as in graph Figure 1C, for
TRPV1 from graph Figure 1E, and for ChR2 the maximal value from the blue
light activation in graph Figure 1G. (B) Bars representing t(1/2) of initiation,
meaning the time required to reach 50% of the maximal response, for the
three channels, calculated from data summarized in Figures 1C,E,H,
respectively. (C) Bars showing t(1/2) of recovery, the time required for 50%
recovery to baseline. Numbers in columns represent the number of cells.
* Indicates statistically significant difference; ns, not significant.
and complex equipment (e.g., confocal microscope, laser, TIRF-
lenses). One way to circumvent these disadvantages is to employ
PI sensors based on Förster resonance energy transfer (FRET):
previously, pleckstrin homology (PH) domains of phospholipase
C δ1 (PLCδ1-PH) fused to CFP and YFP have been used to detect
PI(4,5)P2 concentration dynamics; dissociation of the domains
into the cytosol increases their distance, thus reducing FRET effi-
ciency (Figure 3A) (Varnai and Balla, 1998; Falkenburger et al.,
2010; Hertel et al., 2011). As shown in Figures 3B,C, activation
of Ci-VSP with capsaicin in cells co-expressing TRPV1, PLCδ1-
PH-CFP, and PLCδ1-PH-YFP induced an increase of the CFP
signal and a decrease of the FRET signal, indicating the decrease
in FRET efficiency. Here, we used photodiodes to measure both
CFP and YFP fluorescence emission, demonstrating that the
FRET-based approach eliminates the need for microscopic spa-
tial separation of membrane-bound and cytosolic fluorescence.
We further sought to improve this approach, because consistency
and reliability of this method may suffer from variable expres-
sion stoichiometry of both PH domains and from changes in
fluorescence intensity resulting from sensor translocation. We
therefore developed an intramolecular FRET sensor where bind-
ing of a PI(4,5)P2 binding domain to the membrane affects
FRET efficiency between CFP and YFP flanking this domain
(Figure 3A). Such a sensor based on PLCδ1-PH and anchored
to the plasma membrane via a CaaX-box has been developed
previously and termed Pippi-PI(4,5)P2 (Yoshizaki et al., 2007).
However, dual sensitivity of the PLCδ1-PH sensor domain to
both PI(4,5)P2 and IP3 may be a problem under some exper-
imental conditions (Varnai and Balla, 2006). In contrast, the
tubbyC domain used in the present study combines insensitiv-
ity to IP3 (Szentpetery et al., 2009) with higher sensitivity to
changes in PI(4,5)P2 levels than PLCδ1-PH, as shown previously
(Halaszovich et al., 2009). We thus designed a PI(4,5)P2 sen-
sor, which we termed “Frubby,” where the PLCδ1-PH domain
of the original Pippi PI(4,5)P2 sensor (Yoshizaki et al., 2007)
was replaced by tubbyC as the PI(4,5)P2-binding domain. Deple-
tion of PI(4,5)P2 using Ci-VSP under voltage clamp conditions
showed that Frubby yields a robust, rapid, and readily reversible
change in FRET ratio (Supplementary Figure S2A) as well as a
graded response across a useful dynamic range (Supplementary
Figure S2B).
We went on to combine detection of PI(4,5)P2 changes
using Frubby with activation of Ci-VSP by TRPV1. As shown
in Figure 3C, application of capsaicin to cells co-expressing
Frubby, Ci-VSP and TRPV1 induced a strong FRET ratio change.
Notably, signal amplitude was similar, but signal variability was
smaller and reversibility was more complete compared to the
bi-molecular FRET sensor (Figure 3C).
It should be noted that experiments using Ci-VSP to suppress
PI(4,5)P2 dependent activity of ion channels such as GIRK and
KCNQ2/KCNQ3 have demonstrated that the apparent PI(4,5)P2
affinity of these effectors lies within the dynamic range we
demonstrated for Frubby (Supplementary Figure S2B) and the
degree of PI(4,5)P2 depletion can be expected to be effective on
those targets of PI(4,5)P2 signaling (cf. e.g., Murata et al., 2005;
Iwasaki et al., 2008; Villalba-Galea et al., 2009; Rjasanow et al.,
submitted).
In conclusion, the combination of ligand-controlled activation
of Ci-VSP together with FRET detection using the Frubby sensor
allowed for the temporally precise depletion of PI(4,5)P2 in intact
cells and concomitant monitoring of PI(4,5)P2 changes without
the need for single-cell imaging.
VSP-PTEN Chimera for Functional Analysis of the
Tumor Suppressor PTEN
PTEN is one of the most frequently mutated tumor suppres-
sors in human cancer and exerts its tumor suppressor activ-
ity via direct antagonism of the phosphatidylinositol 3-kinase
(PI3K) signaling pathway by counteracting the PI(3,4,5)P3 pro-
duction via PI3K (Chalhoub and Baker, 2009; Varga et al., 2009;
Hollander et al., 2011).
Development of the chimeric protein PTENCiV, which fully
reproduced the substrate specificity of wild-type PTEN and
could be activated bymembrane depolarization, provided a novel
approach for controlling the activity of PTEN and studying
this important tumor suppressor (Lacroix et al., 2011). Similarly
to the approach we used for Ci-VSP, we attempted to activate
PTENCiV without electrophysiological methods and compare the
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FIGURE 3 | FRET sensors to monitor Ci-VSP activation. (A)
Schematic representation of two different FRET sensors used to
monitor Ci-VSP activity using photometry. PLCδ1-PH-CFP and
PLCδ1-PH-YFP are located at the membrane before Ci-VSP activation
and act as FRET donor and acceptor, respectively. FRET is disturbed
when the sensors translocate to the cytoplasm after activation of
Ci-VSP. Frubby is a construct that allows for intramolecular FRET and
as shown in the schema it is held at the plasma membrane via a
CaaX motif. (B) Representative trace of fluorescence signal from a cell
expressing Ci-VSP, TRPV1 channel, PLCδ1-PH-CFP, and
PLCδ1-PH-YFP. Treatment with capsaicin results in an increase of CFP
and a decrease of FRET signal. (C) FRET ratio traces of the two
FRET sensor systems. Both the PLCδ1-PH–CFP and PLCδ1-PH–YFP
system (e = 15) and Frubby (e = 13) show a robust decrease of FRET
ratio. No decrease in FRET is observed when the catalytically dead
mutant Ci-VSP C363S (e = 6) is used.
phosphatase activity of different PTEN mutants. We selected
TRPV1 for activation of PTENCiV because high extracellular
K+ concentrations interfered with some GFP-tagged biosensors
(Supplementary Figure S3), precluding the use of KCNQ4 or
TASK-3, and activation of ChR2 with blue light is incompatible
with GFP-tagged sensors for PI(3,4,5)P3.
Since PTEN is a PI(3,4)P2/PI(3,4,5)P3 3-phosphatase, we
first tested various sensor domains that specifically bind to
these 3-phosphorylated PIs for their suitability to quantita-
tively assess activity of PTENCiV . Akt-PH-GFP (Servant et al.,
2000) and Btk-PH-GFP (Salim et al., 1996) showed larger
responses than GRP-PH-GFP (Klarlund et al., 1997) (Sup-
plementary Figure S4). Because response kinetics were faster
for Akt-PH than for Btk-PH (Supplementary Figure S4), we
chose Akt-PH-GFP as the most suitable sensor for subsequent
experiments.
For examination of PTEN mutations by these methods,
we focused on Lysine 125, located in the catalytic pocket
of the protein (Figure 4A). PTEN mutations at this position
are frequently found in cancer, according to COSMIC (Cat-
alog of Somatic Mutations in Cancer, http://cancer.sanger.ac.
uk/cancergenome/projects/cosmic/). In addition to oncogenic
K125R and K125N, we also analyzed K125L because all three
PTEN mutants were previously examined with a yeast survival
model (Rodriguez-Escudero et al., 2011), thus allowing for direct
comparison of methods.
When challenged by capsaicin-triggered depolarization, all
three mutants showed impaired phosphatase activity compared
to “wildtype” PTENCiV (Figure 4B). K125R and K125L presented
significantly reduced enzymatic activity, yielding maximum sen-
sor translocation of 61.17 ± 5.48% and 40.43 ± 5.11% relative
to “wildtype” PTENCiV activity respectively, while the K125N
mutation resulted in a complete loss of enzymatic function
(Figure 4C).
PTENCiV Can be Exploited to Test PTEN Inhibitors
Bisperoxovanadium (bpV) compounds are specific PTEN
inhibitors and have been widely used to assess the role of PTEN
in cellular processes (Schmid et al., 2004). They have been
characterized using in vitro phosphatase assays and Western blot
analyses of the phosphorylation of PKB (Protein Kinase B, Akt),
a downstream target of the PTEN pathway. We considered these
compounds as a useful example for exploring the potency of
the PTENCiV/live-cell approach in analyzing the effect of PTEN
modulators in intact cells. We examined the effects of two com-
pounds, bpV(HOpic) where bpV is attached to a polar func-
tional group and bpV(phen) where bpV is attached to a neutral
functional group.
TRPV1 was used to activate PTENCiV as described above.
Here, we measured membrane association of the PTEN activity
sensor Akt-PH-GFP by TIRF microscopy (Lacroix et al., 2011).
TIRF selectively captures fluorescence from the cell membrane,
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FIGURE 4 | Analyzing PTEN mutations using PTENCiV and TRPV1
mediated membrane depolarization. (A) Schematic representation of
PTENCiV. The VSD of Ci-VSP, consisting of four transmembrane domains,
was fused to the N terminal region of PTEN. Point mutations were introduced
at K125 located in the P-loop of the catalytic domain. Asterisks mark
oncogenic mutations as reported at COSMIC database
(http://cancer.sanger.ac.uk/cancergenome/projects/cosmic/). PBM, PIP2
binding module; C-tail, the carboxyl-terminus domain; PDZ, postsynaptic
density protein–Drosophila disc large tumor suppressor–zonula occludens 1
protein domain; P-loop, phosphatase binding loop. (B) Time series traces of
Akt-PH-GFP translocation upon activation with capsaicin in cells
co-expressing TRPV1 channel and WT or mutated PTENCiV. (C) Mean of
Akt-PH-GFP translocation calculated for the last 30 s of capsaicin
application, normalized to the average response measured with WT
PTENCiV. Numbers in columns represent the number of cells. Statistically
significant difference between WT and mutants is marked with *.
thus dissociation of the PI sensor used to monitor PTENCiV
activation results in a decrease of the fluorescent signal.
First, cells were incubated with either bpV compound
overnight and throughout the experiment. As shown in
Figure 5A, both compounds inhibited PTEN activity in a dose-
dependent manner. Nearly complete inhibition was observed
with 10µM of bpV(phen) or bpV(HOpic). Inhibition was par-
tially reversible when cells that were incubated overnight with
10µM of bpV(phen) were washed and incubated with 5mM of
the reducing agent Dithiothreitol (DTT) for 3 h.
To investigate the time course of the inhibition, which is
less easily addressed by conventional biochemical methods,
we monitored the same cells before and after application of
inhibitors. Cells responsive to a first stimulation by capsaicin
were incubated for 30min with 200µM bpV(phen) (lower
concentrations failed to inhibit PTENCiV in acute application,
data not shown). These cells did not respond to a second
application of capsaicin indicating the inhibition of PTENCiV
(Figure 5B, Supplementary Figure S5). Similarly, 30min applica-
tion of 200µMof bpV(HOpic) greatly decreased the phosphatase
activity (Figure 5C, Supplementary Figure S5). Control experi-
ments were performed where no inhibitor was applied between
subsequent capsaicin treatments (Figure 5D, Supplementary Fig-
ure S5). In that case, the second response—although decreased—
remained pronounced. This decreased response might be
explained by incomplete recovery of PI(3,4,5)P3 levels (Supple-
mentary Figure S5, lower trace). The much lower efficacy of
bpV in acute application when compared to overnight incu-
bation may indicate that permeation into the cell membrane
is slow. Indeed, when the inhibitor was applied intracellularly,
the inhibitory concentrations were similar to the concen-
trations required with overnight incubation (Supplementary
Figure S6).
PTENCiV Activation Allows for Rapid Control of
PI3K Downstream Pathways
Themajor role of PTEN is to antagonize the phosphatidylinositol
3-kinase (PI3K) signaling pathway. This pathway is controlled by
the serine-threonine protein kinase Akt (also known as protein
kinase B) which is recruited and activated by plasma membrane
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FIGURE 5 | PTENCiV is inhibited by bisperoxovanadate compounds.
(A) Bars representing the effect of overnight incubation of
bisperoxovanadate compounds on PTENCiV activity. Fluorescence
intensity was acquired with TIRF microscopy of HEK cells expressing
PTENCiV, TRPV1 channel, and Akt-PH-GFP. Decrease in the fluorescence
signal recorded from the membrane is observed upon capsaicin
application. Cells were treated with different concentrations of the PTEN
inhibitors bpV(phen) or bpV(Hopic). Cells that after an overnight incubation
with 10µM bpV(phen) were washed out and incubated for 3 h with 5mM
of the reducing agent DTT showed a partial recovery of phosphatase
activity. (B–D) Graph demonstrating the effect of the inhibitors in real
time. Data is normalized to the time intervals immediately preceding each
capsaicin application. See Supplementary Figure 5 for a presentation of
the data without re-normalization for the second agonist application. (B)
HEK cells that had initially responded to a 100 nM capsaicin activation
were incubated for 30min with 200µM of the inhibitor bpV(phen). After
the 30min incubation they presented no response to a second capsaicin
application (n = 11, e = 4). (C) Application of the inhibitor bpV(Hopic) also
impairs PTENCiVactivity (n = 10, e = 4). (D) Graph showing a control
experiment where no inhibitor was applied between the two capsaicin
applications (n = 9, e = 3). Statistically significant difference between
control and treated samples is marked with *, while the # sign indicates
significant difference between the 10µM bpV(phen) and the DTT treated
samples. Numbers in columns represent the number of cells.
PI(3,4,5)P3 and in turn regulates a plethora of downstream tar-
gets through a cascade of protein kinases (Brazil et al., 2004)
(Figure 6A).
We wondered if our method to rapidly change PTEN activ-
ity might have the potential to interrogate the dynamics of PI3K
signaling. To assess the effect of PTENCiV on downstream tar-
gets of the Akt signaling pathway we utilized the Akt activity
reporter, AktAR, described by Gao and Zhang (2008). AktAR is a
membrane-anchored FRET sensor to monitor the kinase activity
of Akt that is composed of part of the Akt-recognition sequence
of FOXO1 and a forkhead-associated domain (FHA1). Akt-
dependent phosphorylation of FOXO1 leads to dimerization of
the two domains and an increase in the FRET signal, i.e. the FRET
ratio directly correlates to the kinase activity of Akt (Figure 6B).
In cells co-expressing TRPV1, PTENCiV, and AktAR, applica-
tion of capsaicin for 10min indeed led to a decrease of the FRET
signal indicating decreased Akt activity. In contrast, no decrease
was observed when catalytically-dead PTENCiV C363S was co-
expressed (Figure 6C). In conclusion, ligand-induced activation
of PTENCiV does not only allow manipulation of PI(3,4,5)P3
at the plasma membrane, but also control and analysis of the
downstream signaling cascade, including phosphorylation of Akt
substrates in intact living cells.
Discussion
We developed a fast, simple, reversible, and scalable method that
can be used not only as a tool to control PI levels in living cells,
but also to study the tumor suppressor PTEN. The approach
is based on well characterized VSPs, namely the PI(4,5)P2
5-phosphatase Ci-VSP (Iwasaki et al., 2008; Halaszovich et al.,
2009) and the engineered PI(3,4)P2/PI(3,4,5)P3 3-phosphatase
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FIGURE 6 | Activation of PTENCiV leads to rapid dephosphorylation
of FOXO1. (A) PTENCiV activation decreases PI(3,4)P2/PI(3,4,5)P3 levels
which results in Akt’s displacement from the plasma membrane. This
displacement prevents the phosphorylation and activation of Akt by
PDPK1 (3 phosphoinositide dependent kinase 1). Akt is then unable to
phosphorylate downstream targets like FOXO1. (B) Schematic
representation of the Akt activation reporter, AktAR. FOXO1 at the
phosphorylated state dimerizes with the Forkhead associated (FHA)
domain and results in approach of the fluorophores. Activation of
PTENCiV should disrupt this interaction. (C) FRET ratio traces of cells
expressing TRPV1, PTENCiV, and AktAR. Activation of PTENCiV with
100 nM of capsaicin for 10min results in a decrease of the FRET signal,
indicating the rapid dephosphorylation of FOXO1 (n = 11, e = 4 for
PTENCiV; n = 9, e = 3 for PTENCiV C363S).
PTENCiV (Lacroix et al., 2011). To activate these enzymes in liv-
ing cells, the membrane potential must be depolarized. So far,
this required the use of electrophysiological techniques, usually
whole-cell patch clamping formammalian cells. Since suchmeth-
ods are not available to many laboratories, either because of
lack of equipment or electrophysiological expertise, we sought
to find a simpler and broadly applicable method for membrane
depolarization. Our data demonstrate that activation of overex-
pressed cation channels is a simple and powerful method to acti-
vate Ci-VSP or chimeric VSPs and thereby manipulate PI(4,5)P2
and PI(3,4,5)P3 concentrations in a temporally well-controlled
manner.
Currently, widely used methods for acutely altering PI con-
centrations are based on the recruitment of PI metabolizing
enzymes to the membrane through a dimerization strategy,
triggered either by rapamycin (Suh et al., 2006; Varnai et al., 2006)
or via an optogenetic approach (Idevall-Hagren et al., 2012).
Compared to these methods, the main advantage of the VSP-
based approach is the reversibility of PI changes with times for
50% recovery of 12 to 28 s. In contrast, the rapamycin system
is virtually irreversible and with the optogenetic method half-
maximal recovery of PI(4,5)P2, measured as either sensor domain
translocation or KCNQ2/3 current inhibition, required several
minutes (Idevall-Hagren et al., 2012). One additional disadvan-
tage of the optogenetic approach is that its sensitivity to blue and
green light places restrictions on which fluorophores can be used
for imaging / monitoring purposes. On the other hand it allows
for subcellular manipulation of PI concentrations, whereas VSP
activation in our system always affects the entire plasma mem-
brane of the cell. We further note that activation of VSPs by
each of the tested ion channels allowed for a graded depletion
of PI(4,5)P2. This high level of control over PI(4,5)P2 levels may
be used to compare the apparent affinity of intracellular PI(4,5)P2
effectors in a semi-quantitative manner, as we have demonstrated
in earlier work (Halaszovich et al., 2009).
Each of the three classes of channels explored here activated
Ci-VSP with similar efficacy, which was assessed as degree of
translocation of the PI(4,5)P2 sensor tubbyC, tagged with either
GFP or RFP. Although not being a direct quantification of actual
[PI(4,5)P2], this method provides a sufficient means of compar-
ison of degree of PI(4,5)P2 depletion. While we cannot exclude
the possibility that the choice of the tag, which was based on
the technical requirements discussed below, influences the degree
of fluorescence increase seen in the experiments, we expect the
main determinant to be the properties of the PI(4,5)P2 binding
domain itself. Therefore a meaningful comparison of the degree
of Ci-VSP activity can be drawn from experiments even when
differently tagged sensors are used.
Advantages and limitations of each channel type mostly relate
to the technical aspects of channel activation. Depolarization
through constitutively open K+ channels requires full exchange
of bath solution to alter the K+ concentration; in some cases,
high extracellular K+ concentrations interfered with GFP fluo-
rescence (Supplementary Figure S3). Activation of ligand gated
channels does not necessarily require complete bath exchange,
since the ligand can be added to the bath solution, especially
when small concentrations can be used; for the TRPV1 chan-
nel used here, an agonist concentration as low as 100 nM was
sufficient for maximal effect. For plate-reader systems, there is
equipment available to perform such an application of a ligand to
the assay. A disadvantage of using TRPV1 is the requirement for
a Ca2+-free bath solution, although in many cases this will not be
a severe restriction. Also, use of TRPV1 was the method showing
the slowest kinetics, which is probably related to ligand perme-
ation and binding/unbinding. Manipulations of the bath solution
can be avoided altogether when the optogenetic approach using a
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light gated channel (ChR2) is used. Here, we achieved the fastest
response times. Disadvantages of using ChR2 are that a low pH
(6.5) and Ca2+-free bath solution had to be used and that the
spectral characteristics of ChR2 preclude the use of certain wave-
lengths for excitation of fluorophores. Notably, we were not able
to use GFP-tagged PI-sensors and used RFP instead. We would
like to point out that naturally we could only study a subset
of ion channels that potentially can be useful for VSP activa-
tion. Further candidates like e.g., the FMRFamide-gated sodium
channel FaNaC (Lingueglia et al., 1995), which has been used to
depolarize tsA201 cells as well as to activate mammalian neurons
(Scheel et al., 2005; Schanuel et al., 2008), might be better suited
for specific applications and should be considered accordingly.
One caveat when using ion channels for VSP activation is the
PI(4,5)P2 dependence of some of these channels. Regarding those
used in this study, KCNQ4 shows inhibition following PI(4,5)P2
depletion, in contrast to the PI(4,5)P2 insensitive TASK-3 (Lind-
ner et al., 2011), also TRPV1 has been described as PI(4,5)P2
sensitive (Klein et al., 2008). While the PI(4,5)P2 sensitivity of
these two channels was not sufficient to make them unsuitable
for the purpose of VSP activation, for more sensitive channels or
in cell systems showing lower baseline PI(4,5)P2 concentrations
this might not be the case. One such example might be the highly
sensitive R555C mutant of KCNQ1, where even basal Ci-VSP
activity is reported to be sufficient for complete channel deactiva-
tion (Coyan et al., 2014). Therefore when deviating from the ion
channels or cell systems used in the present study their suitability
should be carefully assessed.
Beyond manipulation of PI(4,5)P2 and PI(3,4)P2/PI(3,4,5)P3
levels, the availability of PTENCiV considerably extends the range
of useful applications of the method presented here. The role
of PTEN in pathological conditions like tumors of sporadic and
germline origin and ASDs is well established (Cantley and Neel,
1999; Varga et al., 2009; Hollander et al., 2011). Biochemical
in vitro techniques or a heterologous yeast reconstitution sys-
tem have usually been used to investigate the effect of mutations
on protein function or to study chemical PTEN inhibitors and
activators.
The method we present should provide a useful complemen-
tation of the current spectrum of methods. We note several
potential advantages of this approach. First, our method proved
to be more sensitive than the published yeast-based method
(Rodriguez-Escudero et al., 2011) in assessing the effect of PTEN
mutations (see below). Second, in the living mammalian cell,
PTEN acts on its substrates in the native membrane environ-
ment, which can differ substantially from the composition of
vesicles used to present the potential substrates or even soluble
substrate analogs used in in vitro assays. This might affect activ-
ity or substrate specificity inferred from such experiments. For
example, the human VSP ortholog hVSP1 (also known as TPIP
or TPTE2) was first described as a PI(3,4,5)P3 3-phosphatase
based on in vitro data (Walker et al., 2001). However, recent
experiments in mammalian cells using a voltage sensitive hVSP1
chimera revealed that it is a PI(4,5)P2/PI(3,4,5)P3 5-phosphatase
(Halaszovich et al., 2012). Finally, the new method is applicable
to a wide range of cell types, including cell lines derived from
human tumors, once heterologous expression of the molecular
components (VSP and cation channel) can be achieved in that
cell line.
For demonstration purposes, we studied PTEN mutations,
including known oncogenic mutations. For some of these PTEN
mutations, results obtained with the PTENCiV approach were
consistent with previously published findings from in vitro and
yeast assays (Rodriguez-Escudero et al., 2011). Thus, PI(3,4,5)P3
phosphatase activity was strongly decreased for PTENCiV K125L
and abrogated for PTENCiV K125N (Figures 4B,C). However,
the yeast survival method did not detect any defect of the
PTEN K125R, although the mutant is annotated as an onco-
genic mutation. Our approach indeed detected a decrease of
phosphatase activity by 40%. This finding might explain the
tumorigenic effect of that mutation and also highlights the sen-
sitivity of our approach. As ASD-related mutations have been
shown to decrease but not abrogate PTEN phosphatase activ-
ity (Rodriguez-Escudero et al., 2011), this high sensitivity should
render ourmethod a well-suited tool for testing ASD- and tumor-
associated PTEN mutations.
Similarly, the PTENCiV method enabled analysis of pharma-
cological manipulation of PTEN. In vitro and in vivo, bpV com-
pounds inhibit PTEN at nanomolar concentrations with minimal
cytotoxicity (Schmid et al., 2004). In that study, more indirect
methods like assessing the phosphorylation state of Akt/PKB
were used, whereas we directly monitored PTEN’s substrate
PI(3,4,5)P3 to determine the effect of these inhibitors in living
cells. The bpV compounds have been used to study the involve-
ment of PTEN in signaling, proliferation, apoptosis, and neu-
rogenesis (Band et al., 1997; Batty et al., 2007; Pi et al., 2012;
Tian et al., 2012; Becker et al., 2013); however, higher con-
centrations (200 nM–100µM) were required. We found com-
parable concentrations to effectively inhibit PTEN activity in
our live cell assay. This technique holds promise for high-
throughput screens for novel substances with pharmacologi-
cal activity toward PTEN. Such substances could also include
enhancers of PTEN activity, which might be used for anticancer
therapy.
These findings demonstrate that PTENCiV can be used to
study mutations and compounds affecting the catalytic domain
of PTEN. While this technique has clear advantages in terms of
simplicity and through-put over existing techniques, it might be
unable to detect the effect of mutations or interactions outside
the catalytic domain which might affect PTEN activity, e.g. by
interfering with membrane association. Therefore we view the
VSP-based method not as a complete replacement for, but as a
complement to existing methods.
Moreover, because the PTENCiV method is essentially a real-
time approach in living cells, it can yield insights into the tem-
poral cellular dynamics of PI(4,5)P2 and PI(3,4,5)P3 signaling
that are difficult to obtain with a purely biochemical approach.
As an example, we showed that down-regulation of PI(3,4,5)P3
(and PI(3,4)P2) concentration resulted in a surprisingly rapid
switching-off of signaling by dephosphorylation of intermediates
within the Akt signaling cascade, which (to our knowledge) has
not been appreciated before. This finding points to a rather high
activity of the protein phosphatase(s) that antagonize Akt kinase
activity.
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In summary, we presented a series of simple to use and broadly
applicable methods that provide temporal control of VSPs. This
allows for manipulation of PI levels and subsequently manipula-
tion of their downstream targets. Moreover, using the engineered
voltage sensitive enzyme PTENCiV we suggest a novel method for
charactering this critical tumor suppressor. Further development
of a method combining PTENCiV with an optimized FRET sen-
sor, could create a powerful automated tool to screen for patho-
logical PTEN mutations and for substances affecting activity of
PTEN.
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